Thermosensitive In situ Gelling System for Dermal Drug Delivery of Rutin
- 11 May 2023
- journal article
- research article
- Published by Galenos Yayinevi in Turkish Journal of Pharmaceutical Sciences
- Vol. 20 (2) , 78-83
Abstract
Rutin has been broadly applied for treating several diseases due to its pharmacological activities. However, its low aqueous solubility limits its absorption and bioavailability. This research aims to increase the solubility of rutin using cyclodextrin and to develop a temperature-triggered in situ gelling system for dermal application. The solubility of rutin was increased with sulfobutyl ether-β-cyclodextrin (SBE-β-CD). Rutin- SBE-β-CD inclusion complex was prepared by kneading and freeze dying method. Structural characterization was carried out using differential scanning calorimetry and fourier transform infrared spectroscopy. In situ gel formulations were prepared with pluronic F127 (PF127), a thermosensitive polymer, and chitosan (CH), a natural, biodegradable, and mucoadhesive hydrophilic polymer. In situ gel characteristics such as pH, clarity, gelation temperature, and viscosity were determined. When the solubility diagrams were examined, it was concluded that SBE-β-CD showed a linear increase, therefore, AL-type diagram was selected. The formulations were produced using different amounts of PF127 and a fixed ratio of CH. Three in situ gels were evaluated for their pH, gelling temperature, and the rheological behaviors, and one formulation was selected. It was observed that the formulations had a pH between 6-6.1, and their gelation temperature decreased with increasing PF127 that was between 20°C to 34°C. For the selected formulation (formulation E3), 0.5% rutin and rutin/SBE-β-CD were transferred to the in situ gelling system. Because of in vitro release studies, it was observed that the release of the rutin/SBE-β-CD inclusion complex containing NZ formulation showed a higher burst effect than the others and the release continued for 6 hours. The results indicated that the combination of PF127 and CH can be a hopeful in situ gelling vehicle for dermal delivery of rutin and rutin/SBE-β-CD.Keywords
This publication has 60 references indexed in Scilit:
- Complex of Rutin with β-Cyclodextrin as Potential Delivery SystemPLOS ONE, 2015
- In situ gelling systems: a strategy to improve the bioavailability of ophthalmic pharmaceutical formulationsDrug Discovery Today, 2014
- Hp--CD-VoriconazoleIn SituGelling System for Ocular Drug Delivery:In Vitro, Stability, and Antifungal Activities AssessmentBioMed Research International, 2013
- Effects of surfactant micelles on solubilization and DPPH radical scavenging activity of RutinJournal of Colloid and Interface Science, 2011
- Pharmaceutical applications of cyclodextrins: basic science and product developmentJournal of Pharmacy and Pharmacology, 2010
- Nanostructured Systems Containing Rutin: In Vitro Antioxidant Activity and Photostability StudiesDiscover Nano, 2010
- Anti-inflammatory properties of phenolic compounds and crude extract from Porphyra dentataJournal of Ethnopharmacology, 2010
- Preparation and Solid-State Characterization of Inclusion Complexes Formed Between Miconazole and Methyl-β-CyclodextrinAAPS PharmSciTech, 2008
- A Review of Poloxamer 407 Pharmaceutical and Pharmacological CharacteristicsPharmaceutical Research, 2006
- Study of an alginate/HPMC-based in situ gelling ophthalmic delivery system for gatifloxacinInternational Journal of Pharmaceutics, 2006